Analytical Data
-
Gene name
RCBTB2
- Application
-
Alternative Names
CHC1L; RLG; RCC1-like G exchanging factor; Regulator Of Chromosome Condensation And BTB(POZ)Domain Containing Protein 2; Chromosome Condensation 1-Like
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95199
-
Expression Region
Ala394~Leu519
-
Molecular Weight
18kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RCBTB2, or RCBTB2 (RING CH2 and BTB/POZ domain containing protein 2), is a member of the RCBTB family of proteins known for their roles in various cellular processes, including signal transduction, transcription regulation, and cellular differentiation. Recent studies suggest that RCBTB2 may be implicated in critical biological functions such as cell cycle regulation and neuronal development. Abnormal expression levels of RCBTB2 have been associated with several diseases, including certain cancers and neurodegenerative disorders, highlighting its potential as a therapeutic target. Research into RCBTB2 recombinant protein aims to elucidate its structure-function relationships and regulatory mechanisms, facilitating the understanding of its role in pathophysiological conditions. By producing RCBTB2 as a recombinant protein, scientists can perform biochemical assays, crystallography, and functional studies to explore its interactions with other proteins and its impact on cellular pathways. This can ultimately lead to the development of innovative strategies for disease intervention and the advancement of targeted therapies. Overall, the study of RCBTB2 recombinant protein represents a promising avenue for uncovering novel insights into cellular regulation and potential therapeutic applications.
